Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ

$466.06

$+0.35

(+0.07%)

Regular Market

Madrigal Pharmaceuticals, Inc. (MDGL) Live Price Chart

Last updated: ⁦2026-10-21 18:54:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Madrigal Pharmaceuticals, Inc. (MDGL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $466.06, with a market capitalization of $10.33B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $393.61 to $615.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.33B
Open	$467.90
Day's High	$615.00
Day's Low	$6.60
Previous Close	$467.54
Volume	195.25K
Average Volume	295.69K
P/E Ratio	--
52-Week High	$615.00
52-Week Low	$393.61
Dividend Yield	--
Earnings Date	--

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Price Today

Madrigal Pharmaceuticals, Inc. (MDGL) is currently trading at $466.06 as of 2026-10-21 18:53:00, down 0.32% ($1.48) from the previous close of $467.54

During today's regular trading session, MDGL has traded between $6.60 and $615.00, with a trading volume of 195.25K shares. The current price is near the upper end of today's range.

Madrigal Pharmaceuticals, Inc. (MDGL) 7-Day Stock Price Change

Over the past seven days, Madrigal Pharmaceuticals, Inc. (MDGL) moved from $467.16 to $466.06, representing a decline of 0.24% ($1.10).

The stock traded between $443.48 and $482.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 344.95 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MDGL 52-Week Price Position

Position in Range: 32.7%

52W Low$393.61

52W High$615.00

MDGL is currently trading at $466.06, placing it 32.7% of the way from its 52-week low of $393.61 to its 52-week high of $615.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Madrigal Pharmaceuticals, Inc. (MDGL)?

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

Madrigal Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	915
Exchange	NASDAQ
Company Website	https://www.madrigalpharma.com

How to Buy Madrigal Pharmaceuticals, Inc. (MDGL) Stock on MEXC

Eligible investors can buy real shares of Madrigal Pharmaceuticals, Inc. (MDGL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MDGL and Place Your Order

Open the RealStocks trading page and search for MDGL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Madrigal Pharmaceuticals, Inc. (MDGL) stock price today?

Madrigal Pharmaceuticals, Inc. (MDGL) is currently trading at $ 466.06, down 0.32% ($1.48) from the previous close of $ 467.54. Intraday prices update in real time during regular trading hours.

2.Is MDGL stock going up or down today?

As of 2026-10-21 18:53:00, MDGL is trading at $ 466.06, down 0.32% ($1.48) from its previous close of $ 467.54. The stock has traded between $ 6.60 and $ 615.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is MDGL pre-market price?

As of 2026-10-21 18:53:00, MDGL is trading at $ 474.31 in pre-market trading, up 1.45% ($6.76) from the previous close of $ 467.54. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MDGL after-hours price?

As of 2026-10-21 18:53:00, MDGL is trading at $ 470.63 in after-hours trading, up 0.66% ($3.09) from the regular-session close of $ 467.54. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MDGL stock trading now?

MDGL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MDGL sit relative to its 52-week high and low?

Over the past 52 weeks, MDGL has traded between a low of $ 393.61 and a high of $ 615.00. At $ 466.06, the stock is positioned 32.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Madrigal Pharmaceuticals, Inc. in?

Madrigal Pharmaceuticals, Inc. (MDGL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Madrigal Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Madrigal Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 10.33B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MDGL valued in terms of P/E ratio and EPS?

MDGL trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -14.07. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Madrigal Pharmaceuticals, Inc. pay a dividend?

Madrigal Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.